Brief: Oncocyte Announces 1-For-20 Reverse Stock Split
24/07/2023 19:43
July 24 (Reuters) - OncoCyte Corp OCX.O :
* ONCOCYTE ANNOUNCES 1-FOR-20 REVERSE STOCK SPLIT
* ONCOCYTE - CO'S COMMON STOCK WILL BEGIN TO TRADE ON
POST-SPLIT
BASIS AT MARKET OPEN ON JULY 25
Recent news on Insight Molecular Diagnostics
See all newsBrief: Insight Molecular Diagnostics Enters Amendment No. 2 To Merger Agreement On Sept 15, 2026
Insight Molecular Diagnostics Inc reports results for the quarter ended June 30 - Earnings Summary
Insight Molecular Diagnostics Inc expected to post a loss of 24 cents a share - Earnings Preview
Insight Molecular Diagnostics Q1 loss narrows as costs drop
Brief: Insight Molecular Diagnostics Completes Key Milestones Advancing Graftassuredx Toward FDA Submission